Company Information
USD
0.428
- (1.7%)
NASDAQ:LYEL, LYELL IMMUNOPHARMA, INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Address
201 Haskins Way
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Ms. Catherine J. Friedman
Director
Mr. Robert Taylor Nelsen
Director
Dr. Otis W. Brawley,M.D.
Director
Dr. Lynn Seely,M.D.
CEO/Director/President
Mr. William J. Rieflin
Director
Mr. Hans Edgar Bishop
Director
Mr. Richard D. Klausner
Chairman of the Board/Director/Founder
Dr. Elizabeth G. Nabel, M.D.
Director
Mr. Charles Newton
CFO/Chief Accounting Officer
Mr. Stephen Hill
COO
Dr. Tina Albertson, M.D.
Chief Medical Officer/Other Corporate Officer
Dr. Richard Goold, PhD
Chief Information Officer
Ms. Lisa Ryan
Other Executive Officer
Dr. Gary Lee, PhD
Chief Scientific Officer
Ownership
Institution Holdings
MWG Management Ltd.
20,162,332 (7.939%)
Orland Properties Ltd
15,093,969 (5.944%)
BlackRock Inc
14,302,220 (5.632%)
Vanguard Group Inc
13,604,027 (5.357%)
Foresite Capital Management IV, LLC
8,325,000 (3.278%)
BlackRock Fund Advisors
7,584,163 (2.985%)
T. Rowe Price Associates, Inc.
6,638,883 (2.614%)
Alphabet Inc
5,865,125 (2.309%)
Fidelity Management & Research Company LLC
4,872,282 (1.917%)
Geode Capital Management, LLC
3,937,350 (1.550%)
Individual Holdings
Mr. Hans Edgar Bishop
4,685,614 (1.867%)
Mr. Richard D. Klausner
2,967,834 (1.182%)
Dr. Lynn Seely,M.D.
200,000 (0.079%)
Dr. Gary Lee, PhD
52,700 (0.021%)
Mr. Stephen Hill
48,928 (0.019%)
Mr. Charles Newton
48,729 (0.019%)
Dr. Tina Albertson, M.D.
4,049 (0.002%)
Funds Holdings
T. Rowe Price Health Sciences Fund
5,045,778 (1.986%)
iShares Russell 2000 ETF
4,275,380 (1.683%)
Vanguard Institutional Extnd Mkt Idx Tr
2,328,197 (0.916%)
Vanguard Small Cap Index
2,253,613 (0.887%)
Fidelity Small Cap Index Fund
1,740,940 (0.685%)
iShares Russell 2000 Value ETF
1,629,257 (0.641%)
Vanguard Small Cap Growth Index Fund
1,255,425 (0.494%)
Fidelity Growth Company Commingled Pool
1,227,239 (0.483%)
State Street Russell Small/Mid Cap®
1,015,163 (0.400%)
iShares Biotechnology ETF
941,963 (0.371%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
